ArticlePloS one2026
A gene-specific RNA enrichment protocol for nanopore direct-RNA sequencing.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxford Nanopore direct-RNA sequencing, a third-generation sequencing technology, allows for the analysis of native RNA molecules in their natural cellular state. However, cellular RNA is predominantly composed of ribosomal RNA and transcripts from ubiquitously expressed housekeeping genes, which limits the coverage of transcripts from lowly expressed genes. To address this limitation, targeted sequencing can be employed to enrich read coverage by focusing specifically on genes of interest. Here, we present a step-by-step protocol for gene-specific RNA enrichment followed by Oxford Nanopore direct-RNA sequencing. The enrichment protocol utilizes biotinylated DNA capture probes complementary to the target gene. Following in-solution hybridization of probes to total RNA, a series of stringent washes is applied before elution of the enriched RNA sample. The protocol describes all steps from isolation of cellular total RNA to bioinformatic analyses of raw sequencing data. As a proof of concept, capture probes were designed to specifically enrich all RNA species encoded by the MYCN oncogene. The enrichment protocol successfully isolated RNAs from the MYCN gene, achieving a purification factor of 4.8 × 103. Direct-RNA sequencing of the enriched RNA sample revealed that 65% of the primary mapped reads aligned to MYCN transcripts. We also include a more thorough analysis of the most abundant non-target mapped reads and unmapped reads. This protocol proves to be highly effective in removing unwanted RNA species, delivering robust enrichment for the target gene, and significantly enhancing the efficiency of long-read direct-RNA sequencing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.